← Back to patent-cliff list
CAS 2051-95-8
3-Benzoylpropanoic acid
Codes: SALM-030, (I)263642-2-a, (I)131699-11-a
Application context (from source-drug indications)
AsthmaBudesonide/Salmeterol xinafoateChronic obstructive pulmonary diseaseSalmeterol xinafoateAsthmaSalmeterol xinafoateExercise-induced asthmaSalmeterol xinafoateBronchospasmSalmeterol xinafoateSubmental fat accumulationSalmeterol xinafoate分离性焦虑R-fluoxetineAnxietyR-fluoxetineAnxiety disorderR-fluoxetine
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Budesonide/Salmeterol xinafoate | Tier C — Watch / trade | - |
| Salmeterol xinafoate | Tier C — Watch / trade | - |
| R-fluoxetine | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
3-Benzoylpropanoic acid→Methyl 4-oxo-4-phenylbutanoate→(5S)-5-phenyloxolan-2-one→(4S)-4-hydroxy-4-phenylbutanamide→(6S)-6-phenyl-1,3-oxazinan-2-one→(6S)-3-methyl-6-phenyl-1,3-oxazinan-2-one→(1S)-3-(Methylamino)-1-phenylpropan-1-ol→1-Chloro-4-(trifluoromethyl)benzene
3-Benzoylpropanoic acid→(5R)-5-Phenyloxolan-2-one→(4R)-4-Hydroxy-4-phenylbutanamide→(6R)-6-Phenyl-1,3-oxazinan-2-one→1-Chloro-4-(trifluoromethyl)benzene→(3R)-N-Methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine hydrogen chloride
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.